Monte A Gates

Dr. Monte A Gates


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2006 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
MGMonte A Gates
Monte A Gates
ETEduardo M. Torres
Eduardo M. Torres
AWAnna White
Anna White
RFRosemary A. Fricker‐Gates
Rosemary A. Fricker‐Gates
SDStephen B. Dunnett
Stephen B. Dunnett

Verified
Journal Article
Open access
PDF file
BMBongaerts Maud
Bongaerts Maud
KAKoceila Aizel
Koceila Aizel
ESEmilie Secret
Emilie Secret
AJAudric Jan
Audric Jan
TNTasmin Nahar
Tasmin Nahar
MCMathieu COPPEY
Mathieu COPPEY
The remote actuation of cellular processes such as migration or neuronal outgrowth is a challenge for future therapeutic applications in regenerative medicine. Among the different methods that have been proposed, the use of magnetic nanoparticles appears to be promising, since magnetic fields can act at a distance without interactions with the surrounding biological system. To control biological processes at a subcellular spatial resolution, magnetic nanoparticles can be used either to induce biochemical reactions locally or to apply forces on different elements of the cell. Here, we show that cell migration and neurite outgrowth can be directed by the forces produced by a switchable parallelized array of micro-magnetic pillars, following the passive uptake of nanoparticles. Using live cell imaging, we first demonstrate that adherent cell migration can be biased toward magnetic pillars and that cells can be reversibly trapped onto these pillars. Second, using differentiated neuronal cells we were able to induce events of neurite outgrowth in the direction of the pillars without impending cell viability. Our results show that the range of forces applied needs to be adapted precisely to the cellular process under consideration. We propose that cellular actuation is the result of the force on the plasma membrane caused by magnetically filled endo-compartments, which exert a pulling force on the cell periphery.

28 April 2014 in Proteome Science
Verified
Journal Article
Open access
PDF file
Heidi FullerHeidi Fuller
Heidi Fuller
MHMaica Llavero Hurtado
Maica Llavero Hurtado
Thomas WishartThomas Wishart
Thomas Wishart
MGMonte A Gates
Monte A Gates
Idiopathic Parkinson’s disease is marked by degeneration of dopamine neurons projecting from the substantia nigra to the striatum. Although proteins expressed by the target striatum can positively affect the viability and growth of dopaminergic neurons, very little is known about the molecular response of the striatum as nigro-striatal denervation progresses. Here, iTRAQ labelling and MALDI TOF/TOF mass spectrometry have been used to quantitatively compare the striatal proteome of rats before, during, and after 6-OHDA induced dopamine denervation.

9 November 2022 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
KDK. Dhillon
K. Dhillon
KAK. Aizel
K. Aizel
TBT. J. Broomhall
T. J. Broomhall
ESEmilie Secret
Emilie Secret
TGT. Goodman
T. Goodman
MGMonte A Gates
Monte A Gates
A challenge in current stem cell therapies for Parkinson's disease (PD) is controlling neuronal outgrowth from the substantia nigra towards the targeted area where connectivity is required in the striatum. Here we present progress towards controlling directional neurite extensions through the application of iron-oxide magnetic nanoparticles (MNPs) labelled neuronal cells combined with a magnetic array generating large spatially variant field gradients (greater than 20 T m −1 ). We investigated the viability of this approach in both two-dimensional and organotypic brain slice models and validated the observed changes in neurite directionality using mathematical models. Results showed that MNP-labelled cells exhibited a shift in directional neurite outgrowth when cultured in a magnetic field gradient, which broadly agreed with mathematical modelling of the magnetic force gradients and predicted MNP force direction. We translated our approach to an ex vivo rat brain slice where we observed directional neurite outgrowth of transplanted MNP-labelled cells from the substantia nigra towards the striatum. The improved directionality highlights the viability of this approach as a remote-control methodology for the control and manipulation of cellular growth for regenerative medicine applications. This study presents a new tool to overcome challenges faced in the development of new therapies for PD.

1 November 2015 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
Heidi FullerHeidi Fuller
Heidi Fuller
RSRobert Slade
Robert Slade
NMNatasa Jovanov Milosevic
Natasa Jovanov Milosevic
MLMirjana Babić Leko
Mirjana Babić Leko
GSGoran Sedmak
Goran Sedmak
MGMonte A Gates
Monte A Gates

3 September 2024 in Biology
Verified
Journal Article
Open access
PDF file
VBValentina Basso
Valentina Basso
MDMàté D. Döbrössy
Màté D. Döbrössy
LTLachlan H. Thompson
Lachlan H. Thompson
DKDeniz Kirik
Deniz Kirik
Heidi FullerHeidi Fuller
Heidi Fuller
MGMonte A Gates
Monte A Gates
Dopaminergic neurons in the ventral tegmental area (VTA) and the substantia nigra pars compacta (SNpc) comprise around 75% of all dopaminergic neurons in the human brain. While both groups of dopaminergic neurons are in close proximity in the midbrain and partially overlap, development, function, and impairments in these two classes of neurons are highly diverse. The molecular and cellular mechanisms underlying these differences are not yet fully understood, but research over the past decade has highlighted the need to differentiate between these two classes of dopaminergic neurons during their development and in the mature brain. This differentiation is crucial not only for understanding fundamental circuitry formation in the brain but also for developing therapies targeted to specific dopaminergic neuron classes without affecting others. In this review, we summarize the state of the art in our understanding of the differences between the dopaminergic neurons of the VTA and the SNpc, such as anatomy, structure, morphology, output and input, electrophysiology, development, and disorders, and discuss the current technologies and methods available for studying these two classes of dopaminergic neurons, highlighting their advantages, limitations, and the necessary improvements required to achieve more-precise therapeutic interventions.